The “New Normal” of Cancer Treatment Delays Is Nothing New-Reference-Cited by-同舟云学术

The “New Normal” of Cancer Treatment Delays Is Nothing New

Published:2020-12-14 Issue:12 Volume:3 Page:e2030507
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Baum Laura Van Metre¹,Kline Kathryn²,Smith Cardinale B.³

Affiliation:

1. Division of Hematology and Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee

2. Division of Hematology/Oncology, University of Maryland Medical Center, Baltimore, Maryland

3. Department of Geriatrics and Palliative Medicine and Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York City, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2774095/baum_2020_ic_200211_1607354046.85495.pdf

Reference7 articles.

1. Assessment of time-to-treatment initiation and survival in a cohort of patients with common cancers.;Cone;JAMA Netw Open,2020

2. Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US.;Alexander;JAMA Netw Open,2020

3. Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial.;Lohr;Med Care,1986

4. Financial toxicity in adults with cancer: adverse outcomes and noncompliance.;Knight;J Oncol Pract,2018

5. Association of primary care physician supply with population mortality in the United States, 2005-2015.;Basu;JAMA Intern Med,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Change in Tumor Naming: Exploring the Complexities and Considerations of Shifting Toward Molecular Classifications;Journal of Clinical Oncology;2024-06-27

2. Access to New Clinic Appointments for Patients With Cancer;JAMA Network Open;2024-06-07

3. Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic;Current Problems in Cancer;2022-12